Alkem
Manufacturing · India · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Devashish Bldg Alkem House Senapati Bapa...Phone Number
+91 2239829999Website
www.alkemlabs.comRevenue
$1.5 BillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
4
1
1
1
1
About Alkem
Alkem is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company was established in 1973 and is headquartered in Mumbai, India.Explore more
Alkem Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alkem your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Alkem had a recent Job posting/layoffs
Alkem, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Alkem is spiking on competitors!
Earning: See what the market has to say on Alkem recently announced quarterly report
Funding: Get notified immidiatlly once Alkem has new funding data
Congratulate Masked Content for being promoted to Masked Content at Alkem
Product Launch: Get notified when Alkem launches new products
Website visits: Recent activity has been detected on your website
Check if Alkem has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Alkem as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Alkem is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Alkem is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alkem.
Alkem financials insights
Gather financial insights about Alkem, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$205.1M
Alkem Tech Stack
A closer look at the technologies used by Alkem
See more technologies
Most Recent Scoops
Hiring Plans
Alkem has more open roles in Marketing than it has had at any time in the past 12 months. Technologies mentioned include: Google Analytics, Google Ads, and Amazon Advertising.
Hiring Plans
Project
Intellectual Property, Lawsuits, Legal Affairs, Settlement, Pharmaceuticals
Hiring Plans
Alkem has more open roles in Finance than it has had at any time in the past 12 months. Areas of expertise include: External Audit Management, Statutory Audit, Know Your Customer, Cash Flow Improvement, Commercial Management, Process Optimization, and Financial Business Solution.
Hiring Plans
Hiring Plans
Alkem has more open roles in Medical & Health than it has had at any time in the past 12 months. Areas of expertise include: Critical Care.
Hiring Plans
Hiring Plans
Hiring Plans
Alkem News & Media
Axsome Therapeutics Settles SUNOSI® (solriamfetol) Patent Litigation with Alkem Laboratories Ltd.
NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has entered into a settlement agreement with Alkem Laboratories Ltd. (Alkem) resolving patent litigation related to Axsome’s product SUNOSI® (solriamfetol). The litigation, which is pending in the United States District Court for the District of New Jersey, resulted from subAlkem MedTech to acquire 55% stake in Occlutech for €99.4 million
Alkem Laboratories' devices arm to acquire controlling stake in Swiss cardiac implant maker, marking entry into global structural heart segmentSonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India
Sonnet to receive $1.0 million in upfront payment and up to an additional $1.0 million in milestone payments with a royalty in the low double digits on net sales, less certain expenses, in the India marketFirst Patient in Biosergen Clinical Trial Treating with BSG005 for Life Threatening Fungal Infection
Stockholm, Sweden – July 12, 2024 – Biosergen AB (“Biosergen”) is pleased to announce that the first patient suffering from an invasive fungal infection has been dosed with BSG005 as rescue therapy. ‘Today marks a significant milestone as the first patient has received the first dose of our lead candidate BSG005. The goal with the study is to increase survival rates for these very ill patients with difficult to treat fungal strains or/and with resistance
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alkem
Sign Up For FreeTo access detailed company insights
Alkem is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company was established in 1973 and is headquartered in Mumbai, India.... Read More
